通过调节EDAR和BNC2基因表达的生物活性材料改善细
Seonju Lee1, Sanghyun Ye1, Mina Kim1
1LG Household and Health Care, R & D Center, Seoul 07795, Republic of Korea.
Biomolecules
|March 28, 2024
概括
这项研究确定了参与皮肤衰老的关键基因 (EDAR和BNC2),并开发了一种新的抗纹配方. 这种新配方有效地减少纹,增强原蛋白,在不引起刺激的情况下表现优于视网醇.
科学领域:
- 皮肤病学 皮肤病学
- 遗传学 是一个遗传学.
- 化品科学 化品科学
背景情况:
- 皮肤衰老是一个复杂的过程,受内在和外在因素的影响.
- 对抗纹的高效抗衰老成分的需求越来越大.
- 现有的改善纹的材料往往在有效性上有局限性.
研究的目的:
- 研究在全基因组关联研究 (GWAS) 中发现的与纹相关的基因机制.
- 确定调节这些特定基因的新成分.
- 开发和验证一种高于当前标准的有效抗纹配方.
主要方法:
- 选择了两个候选基因,EDAR和BNC2,与周口腔纹相关.
- 对人类皮肤细胞系 (角质细胞和纤维细胞) 进行了体外实验,以研究基因功能.
- 使用细胞系模型,确定并验证了调节EDAR和BNC2表达的成分.
- 开发了一种新的抗纹配方,并进行了人类临床试验.
主要成果:
- 证实EDAR和BNC2在皮肤衰老机制中的作用.
- 确定了有效调节这些基因表达的特定成分.
- 开发的配方在3D皮肤模型中展示了增强的皮肤原蛋白生产.
- 临床试验显示,该配方在8周内与视网醇相比,显著改善了眼下纹.
- 该配方没有表现出皮肤刺激等不良副作用.
结论:
- 该研究成功地确定了纹改善的新目标和成分.
- 开发了一种新的抗纹配方,其疗效和安全性优于雷丁醇.
- 这项研究提供了一个有希望的,耐受性良好的解决方案,用于对抗皮肤衰老和纹.
相关概念视频
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:12Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
01:02Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K